U.S. Markets open in 3 hrs 57 mins

Bioscience for a Better Tomorrow - Exploring Recent Breakthroughs in Medical Technology on Advancements TV Series

Discover how innovations in bioscience and technology are making a difference.

JUPITER, Fla., July 31, 2019 /PRNewswire-PRWeb/ -- Advancements with Ted Danson to focus on innovative medical technologies for personalized treatment. Check your local listings for more information.

Factor Bioscience Inc. (Factor) is pioneering nucleic-acid and cell-based technologies to advance the study and treatment of cancer and genetic and age-related diseases. This segment of Advancements will explore how Factor Bioscience is building the future of regenerative medicine by targeting and repairing the molecular origins of disease.

"Factor is excited to participate in Advancements and to share our discoveries in the burgeoning field of engineered cellular medicine," explains Dr. Matt Angel, Co-Founder and CEO of Factor Bioscience. "These new technologies will allow us to fundamentally alter the way our bodies function, to effectively treat, and eventually eliminate currently untreatable diseases."

The show will highlight Factor's scientists, who developed the fastest, highest-efficiency method for reprogramming somatic cells to a pluripotent stem-cell state – a key invention now recognized by numerous patents. Viewers will see how this technology, which enables the production of patient-specific engineered cells for transplantation, has wide-ranging applications in cancer, neurodegenerative diseases, including Alzheimer's disease and autoimmune diseases, along with multiple sclerosis and personalized regenerative medicine.

The technologies underlying this breakthrough also form the foundation of Factor's protein-replacement and gene-editing platforms, allowing the company to target disease at the molecular level.

About Factor Bioscience:
Based in Cambridge, Massachusetts, Factor Bioscience is developing nucleic-acid and cell-based therapeutics using its patented mRNA, cell-reprogramming, and gene-editing technologies. Factor is focused on creating precision medical treatments, including engineered cellular medicines for people living with cancer and serious genetic and age-related diseases.

For more information, visit: http://www.factorbio.com.

About Advancements and DMG Productions:
The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today's consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more information, please visit http://www.AdvancementsTV.com or call Richard Lubin at 866-496-4065.